|
Viewing 1 - 5 out of 5 Blogs.
The growing demand for greater accuracy, increased flexibility and reduced errors has prompted biopharmaceutical industry stakeholders to consider shifting from manually operated systems to automated systems for efficient liquid handling Roots Analysis is pleased to announce the publication of its recent study, titled, “Automated Liquid Handling Systems Market, 2023-2035.” The report features an extensive study of the current market landscape, market size and future potential of the liquid handling automation systems market, over the forecast period. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. Key takeaways of the automated liquid handling systems market includes: § An executive summary of the insights captured during our research. § A general overview of liquid handling systems, along with comparison between manual, semi-automated and automated liquid handling systems. § A detailed assessment of the current market landscape of automated pipetting systems, based on several relevant parameters. § A detailed competitiveness analysis of automated pipetting system providers based on several relevant parameters § Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated pipetting systems across North America, Europe and Asia-Pacific and rest of the world. § A detailed assessment of the current market landscape of automated microplate washers, based on several relevant parameters. § A detailed competitiveness analysis of automated microplate washer providers based on several relevant parameters. § Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated microplate washers across North America, Europe and Asia-Pacific and rest of the world. § A detailed analysis of partnerships inked between stakeholders engaged in this industry since 2018. § An in-depth analysis of various patents that have been filed / granted related to automated liquid handling systems since 2018. § A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework. § A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Automated Pipetting Systems Market § Pipetting Technology § Contact Technology § Air Displacement Technology § Piston / Positive Displacement Technology § Acoustic Technology § Free-jet Technology § Modality § Fixed Tips § Disposable Tips § Type of Instrument § Standalone § Individual Benchtop Workstation § Multi Instrument Systems § Others § Applications § Serial Dilution § Plate Replication § PCR / qPCR Setup § Plate Reformatting § High-throughput Screening § Whole Genome Amplification § Cell Culture § Other Applications § End User § Biotechnology and Pharmaceutical Companies § Academic and Government Research Institutes § Hospitals and Diagnostic Centers § Other End Users § Key Geographical Regions § North America § Europe § Asia-Pacific § Middle East and North Africa § Latin America Automated Microplate Washers Market § Washing Technology § Ultrasonic Technology § Acoustic Technology § Centrifugal Technology § Application § ELISA § Cell-based Assays § Bead Washing § Other Applications § End-user § Biotechnology and Pharmaceutical Companies § Academic and Government Research Institutes § Hospitals and Diagnostic Centers § Other End Users § Key Geographical Regions § North America § Europe § Asia-Pacific § Middle East and North Africa § Latin America Key companies covered in the report § Agilent Technologies § Beckman Coulter Life Sciences § Eppendorf § Hamilton Robotics § MyGenostics § Tecan § Thermo Fisher Scientific To view more details on this report, click on the link https://www.rootsanalysis.com/reports/automated-liquid-handling-systems-market.html News article Global Cell Free Expression Market Learn from experts: do you know about these emerging industry trends? Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry Top 10 Companies Offering Oral Solid Dosage Manufacturing Services About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
In order to accommodate the growing demand for higher accuracy, greater resolution and improved sensitivity in analytical processes, various industry stakeholders are engaged in the development of novel cytometry platforms with advanced Roots Analysis has announced the addition of “Global Cell CytometryMarket: Focus on High Throughput Flow Cytometry and Image Cytometry, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the cell cytometers, mainly high throughput flow cytometers and image cytometers, in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes: § A general overview of cell cytometry, featuring information on different types of cytometry, along with details on their advantages and limitations. § A detailed assessment of the current market landscape of high throughput flow cytometers. § Detailed product competitiveness analysis of various high throughput flow cytometers. § A detailed assessment of the current market landscape of image cytometers. § Detailed product competitiveness analysis of various image cytometers. § Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) high throughput flow cytometers and image cytometers. § An insightful analysis of the recent partnerships that have been inked within the global cell cytometry industry, since 2017. § An insightful analysis of the recent developments, including insights on the funding activity in this domain and global events that have been organized within the global cell cytometry industry. § An analysis of the patents filed / granted for needlestick safety injection devices, since 2020. § A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) The financial opportunity within the cell cytometry market has been analyzed across the following segments: § Type of Cytometer § High Throughput Flow Cytometer § Image Cytometer § Company Size § Very Small § Small § Mid-sized § Large § Very Large § Key Geographical Regions § North America § Europe § Asia-Pacific § Rest of the World Key companies covered in the report § Agilent § Beckman Coulter Life Sciences § Becton Dickinson § Bio-Rad § Chemotec § Milkotronic § Nexcelom Bioscinces § Sartorius § Sony Biotechnology § Thermo Fischer Scientific § Union Biometrica Get more details on the Cell Cytometry Market report https://www.rootsanalysis.com/reports/cell-cytometry-market.html Learn from experts: do you know about these emerging industry trends? Exploring AI-based Digital Pathology Rare Kidney Disorders: Future Miracle Drugs About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
Tags: Flow Cytometry Companies High Throughput Flow Cytometry Imaging Flow Cyto
The phenomenal success of RNA-based products in tackling the COVID-19 pandemic, globally, as well as their potential to actualize the concept of personalized medicine has resulted in a significant growth in the investment activity in this sector. Roots Analysis is pleased to announce the publication of its recent study, titled, “Investor Series: Opportunities in the RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)”. The report provides detailed information on the RNA therapeutics market, covering various RNA therapies, including RNAi therapies, RNA aptamers, and mRNA therapies and vaccines. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, over the coming decade. The information in this report has been presented across multiple deliverables, featuring MS Excel sheets (some of which include interactive elements) and a MS PowerPoint deck, which summarizes the key takeaways from the project and insights drawn from the curated data. Amongst other elements, the report includes: § An introduction to RNA therapeutics, highlighting prominent barriers to the development and success of RNA therapies. § A detailed analysis of RNA therapeutics focused companies that were established post-2006. § An assessment of the various products, offered by the key innovator companies. § An informed perspective on the value proposition of the companies captured in the report. § A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in the development of RNA therapeutics. § A detailed analysis of the RNA therapeutics funding and RNA therapeutics investment activity that has taken place in this domain, since 2011. § A proprietary analysis defining a basis for estimating the relative valuation of private companies, among the key innovators discussed in this report. § An elaborate review of the overall RNA therapeutics market from a financial perspective, including detailed fundamental and technical analysis. § A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology-related risks, and social, economic, environmental and political risks.. § A case study where RNA therapeutics investors have exited various RNA therapeutics-related ventures, offering insights on returns on investment received. § A key acquisition targets analysis, based on the insights generated during the course of this study. § A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below): § Type of Therapy § mRNA Vaccines and Therapeutics § RNAi Therapeutics § RNA Aptamers § Therapeutic Area § Infectious Diseases § Genetic Disorders § Haematological Disorders § Metabolic Disorders § Ocular Disorders § Oncological Disorders § Renal Disorders § Route of Administration § Intradermal § Intramuscular § Intravenous § Intravitreal § Ophthalmic § Subcutaneous § Key Geographies § North America § Europe § Asia-Pacific § Middle East and North Africa § Latin America The research also includes detailed profiles of key public ventures engaged in the development of RNA therapeutics; each profile features a brief overview of the company, along with information on its management team, insights from its balance sheet (if available), as well as details related to its product portfolio, recent developments and key financials (including company investment highlights, company fundamental and company technical analysis). § Arcturus Therapeutics § Ascletis Pharma § Avidity Biosciences § BioNtech § CanSino Biologics § Gritstone bio § IVERIC bio § Moderna § Phio Pharmaceuticals § Vir Biotechnology To view more details on this report, click on the link https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html Learn from experts: do you know about these emerging industry trends? Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
Tags: RNA Therapeutics Fumding RNA Therapeutics Investment RNA Therapeutics Inv
The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future. The financial opportunity within the SMOs market has been analyzed across the following segments: § Type of Printing Technology § VAT Polymerization Technology § Powder Bed Fusion Technology § Polyjet Technology § Metal Extrusion Technology § Other Technologies § Application Area § Prosthodontics § Orthodontics § Dental Implants § Other Applications § Type of Printing Material § Resins § Plastics § Metals § Metals § Other Material § Key Geographical Regions § North America § Europe § Asia-Pacific § Latin America § Middle East and North Africa § Rest of the World The Dental 3D Printing Market, 2022 – 2035 report studies dental 3D printers manufacturers in detail and features the following companies, which we identified to be key players in this domain: § 3D Systems § Asiga § BEGO § Carbon § Digital Wax Systems (DWS) § Formlabs § Prodways § Rapid Shape § SprintRay § Stratasys Table of Contents 1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Product Competitive Analysis 6. Company Profiles
7. Partnerships and Collaborations
8. Patent Analysis
9. Bowman Clock Pricing
10. Market Forecast and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies And Organizations Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html Learn from experts: do you know about these emerging industry trends? Digital Therapies: The “Digital Pills” of current generation Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
Tags: 3d Printed Dental Implants 3d Printing Dental Implants Dental 3d Printing
Roots Analysis has done a detailed study on Exosome Therapeutics Market, 2022-2040, covering key aspects of the industry and identifying future growth opportunities Key Market Insights § Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies § The current pipeline features more than 120 exosome therapeutics that are being evaluated across different phases of development; most of these are designed for intravenous administration § 3,000+ patients have been recruited / enrolled in clinical trials evaluating exosome related therapies and biomarkers across different geographies § More than 530 grants have been awarded for the ongoing R&D efforts for exosome therapeutics; University of California has been awarded the maximum grant amount of USD 21 million § A variety of investors, having realized the benefits and future opportunities in this field, have invested more than USD 570 million across more than 30 instances, since 2017 § The rising interest of stakeholders in exosome therapeutics is also reflected by the increasing number of partnerships established by various industry and non-industry players § Stakeholders have participated in various global events to discuss the research outcomes, and affiliated challenges as well as opportunities existing in this domain § At present, more than 30 start-ups are driving innovation in this domain; a variety of R&D initiatives have been undertaken by these players over the last few years for the development of exosometherapeutics § Lack of efficacy, COVID-19 pandemic, limited patient enrollment, and scarce funding are among the key reasons that have led to the discontinuation of studies sponsored by various industry and non-industry players § With the rising demand for therapeutic advances in drug safety, the market of exosome therapeutics is expected to grow at an annualized rate of 41% between 2029-2040 § The projected market opportunity is likely to be well distributed across different routes of administration, types of formulations and key geographical regions Table of Contents 1. PREFACE 1.1. Scope of the Report 1.2. Market Segmentation 1.3. Research Methodology 1.4. Key Questions Answered 1.5. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Overview of Exosomes 3.2. Exosome Biogenesis 3.3. Applications of Exosomes 3.4. Mechanism of Exosome Therapy 3.5. Advantages of Exosome Therapies 3.6. Risks and Future Perspectives Associated with Exosome Therapeutics 4. EXOSOME THERAPEUTICS: MARKET LANDSCAPE 4.1. Analysis Methodology and Key Parameters 4.2. Exosome Therapeutics Market Landscape 4.3. Exosome Therapeutics Developers 5. EXOSOME THERAPEUTICS DEVELOPERS: COMPANY PROFILES 5.1. Coya Therapeutics 5.2. Codiak BioSciences 5.4. Evox Therapeutics 5.5. Curexsys 5.6. EV Therapeutics 5.7. SHIFTBIO 6. EXOSOME THERAPEUTICS: DRUG PROFILES 6.1. AEGLE Therapeutics 6.2. AVEM Healthcare 6.3. Cellular Biomedicine Group 6.4. OBCTCD24 6.5. ReNeuron 6.6. Stem Cell Medicine 7. CLINICAL TRIAL ANALYSIS 7.1. Analysis Methodology and Key Parameters 7.2. Exosome Therapeutics: List of Clinical Trials 8. ACADEMIC GRANT ANALYSIS 8.1. Analysis Methodology and Key Parameters 8.2. Exosome Therapeutics: List of Academic Grants 8.3. Analysis by Year of Grants Awarded 8.4. Analysis by Amount Awarded per Year 8.5. Analysis by Type of Funding Institute Center 8.6. Analysis by Support Period 8.7. Analysis by Purpose of Grant 8.8. Word Cloud Analysis: Emerging Focus Area 8.9. Analysis by Grant Activity Code 8.10. Analysis by Location of Recipient Organizations 8.11. Popular Recipient Organizations: Analysis by Number of Grants 8.12. Popular Recipient Organizations: Analysis by Amount Awarded 8.13. Analysis by Type of Recipient Organization 8.14. Analysis by Study Section 8.15. Analysis by Type of Grant Application 8.16. Analysis by Funding Institute Center and Support Year 9. GLOBAL EVENT ANALYSIS 9.1. Chapter Overview 9.2. Scope and Methodology 9.3. List of Global Events Related to Exosomes 10. PARTNERSHIPS AND COLLABORATIONS 10.1. Chapter Overview 10.2. Partnership Models 10.3. Exosome Therapeutics: List of Partnerships and Collaborations 11. FUNDING AND INVESTMENT ANALYSIS 11.1. Analysis Methodology and Key Parameters 11.2. Type of Funding 11.3. Exosome Therapeutics: List of Funding Instances 11.4. Analysis by Year of Funding 11.5. Analysis by Amount Invested 11.6. Analysis by Type of Funding 11.7. Analysis by Type of Funding and Amount Invested 11.8. Analysis by Purpose of Funding 11.9. Analysis by Target Disease Indication(s) 11.10. Analysis by Therapeutic Area 11.11. Most Active Players: Analysis by Number of Funding Instances 11.12. Most Active Players: Analysis by Amount Raised 11.13. Active Investors: Analysis by Number of Funding Instances 11.14. Distribution by Geography 11.15. Summary of Funding Activity 12. START-UP HEALTH INDEXING 12.1. Analysis Methodology and Key Parameters 12.2. Analysis by Pipeline Strength 12.3. Analysis by Pipeline Maturity 12.4. Analysis by Indication Diversity 12.5. Analysis by Number of Partnerships 12.6. Analysis by Financial Support 12.7. Start-up Health Indexing: Roots Analysis Perspective 12.8. Most Active Start-ups 13. CASE STUDY: EXOSOME DEVELOPMENT AND MANUFACTURING SERVICE PROVIDERS 13.1. Chapter Overview 13.2. Exosome Development and Manufacturing Service Providers Landscape 14. DRUG FAILURE ANALYSIS 14.1. Methodology and Key Parameters 14.2. Exosome Therapeutics: List of Failed Drug Candidates 15. MARKET SIZING AND OPPORTUNITY ANALYSIS 15.1. Forecast Methodology and Key Assumptions 15.2. Global Exosome Therapeutics Market, 2029-2040 16. EXECUTIVE INSIGHTS 17. APPENDIX 1: TABULATED DATA 18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html Learn from experts: do you know about these emerging industry trends? Exploring AI-based Digital Pathology Rare Kidney Disorders: Future Miracle Drugs Learn from our recently published whitepaper:-
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
Tags: Exosome Therapy Exosome Diagnostics Exosome Companies Market Research M
|
Favorites
Digg
Del.icio.us
Facebook
Furl
Magnolia
StumbleUpon
Google
Yahoo MyWeb
